US FDA lifts partial clinical hold on Rezolute’s blood sugar treatment

(Reuters) – Rezolute Inc said on Monday the U.S. Food and Drug Administration has removed the partial clinical hold on its late-stage study testing its experimental treatment for low blood sugar.

(Reporting by Sneha S K; Editing by Vijay Kishore)